People in the presymptomatic stages of Parkinson’s disease have distinct patterns of stimulated immune responses relative to those with clinically diagnosed disease or individuals who do not have Parkinson’s, according to a new study. In particular, the release of certain immune signaling proteins from isolated and stimulated immune cells…
The Parkinson’s and Movement Disorder (PMD) Alliance, a U.S.-based nonprofit, is seeking participants willing to take part in an online survey about the experiences of patients and caregivers with off time in Parkinson’s disease. Off time, or periods when medication wears off and symptoms return,…
Angels on Call Homecare has received the 2025 Best of Home Care – Leader in Experience Award for their work providing care to people with Parkinson’s disease and dementia. “This award is a powerful reminder of our commitment to revolutionizing the experience of care,” Eric Dalton, vice president…
The U.S. Food and Drug Administrated (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) status to AAV-GAD, MeiraGTx’s gene therapy for Parkinson’s disease, the company has announced. The designation was granted based on data from three clinical studies showing the treatment eased motor symptoms and improved the quality…
Hillhurst Biopharmaceuticals said it’s been awarded $6.3 million to fund a Phase 2a clinical study to test the efficacy of HBI-002, its low-dose liquid formulation of carbon monoxide, in preserving dopaminergic neurons, those that are lost to Parkinson’s disease, with the goal of slowing or stopping disease progression. The…
The first three patients treated with ANPD001, a cell therapy for Parkinson’s disease, showed reduced motor symptoms and improved daily functioning over six months, without any serious side effects. That’s according to early data from the Phase 1/2a ASPIRO (NCT06344026) study, an open-label clinical trial testing the…
Two University of Michigan-Flint doctorate students received a $50,000 grant to support diversity among exercise providers offering care to people with Parkinson’s disease. The grant, from The Michigan Health Equity Challenge, will help the pair’s Move to Represent initiative train 10 physical and occupational therapists of color to…
Using advanced diagnostic tools — such as different types of brain scans and methods that employ artificial intelligence (AI) — may help detect early signs of Parkinson’s that precede the onset of the disease’s motor symptoms, according to a new review study. The researchers noted that employing these AI-based…
Nerve cells in the brain that are responsible for processing smells and sight show deficits in Parkinson’s disease, according to research done in a mouse model. The findings may lay the groundwork for new approaches to diagnose Parkinson’s, according to scientists. “I think this work is a nice first…
Neuroimaging company Xingimaging has announced the launch of the NX PET Camera, a new tool for positron emission tomography (PET) imaging that aims to accelerate research into Parkinson’s disease. The novel tool, for use in PET imaging scans, “offers cutting-edge imaging capabilities, providing researchers with unparalleled precision in…
Get regular updates to your inbox.
